Advertisement
Screener

Tango Therapeutics, Inc. (TNGX) Cash and Cash Equivalents, Period Increase (Decrease)

2.4 / 5 stars · 26/54 Roast Me

Tango Therapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

Tango Therapeutics, Inc. (TNGX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$731.15 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-08-09

  • Tango Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$675.52K.
  • Tango Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$55.63K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 1 monthCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 4 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 7 month
2021-06-30-$675.52K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$731.15K
10-Q · filed 2021-08-09
2021-03-31-$55.63K
10-Q · filed 2021-05-14
2020-12-31$1.31M
10-K · filed 2021-03-31
2020-09-30$1.55M
10-Q · filed 2020-11-13
2020-06-30$24.99K
10-Q · filed 2021-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Veradermics, Inc (MANE)United States$4.839B
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15